- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/31 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Patent holdings for IPC class C07K 14/31
Total number of patents in this class: 827
10-year publication summary
|
52
|
51
|
62
|
48
|
51
|
43
|
53
|
49
|
39
|
18
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cytiva BioProcess R&D AB | 316 |
56 |
| Affibody AB | 111 |
32 |
| The University of Chicago | 1468 |
27 |
| Navigo Proteins GmbH | 123 |
24 |
| Glaxosmithkline Biologicals S.A. | 1606 |
21 |
| Roche Sequencing Solutions, Inc. | 700 |
21 |
| Kaneka Corporation | 4630 |
16 |
| New York University | 1813 |
15 |
| Children's Medical Center Corporation | 1925 |
14 |
| Evaxion Biotech A/S | 53 |
13 |
| The Regents of the University of California | 20502 |
12 |
| JSR Corporation | 2550 |
10 |
| GE Healthcare Bio-Sciences AB | 523 |
10 |
| EMD Millipore Corporation | 642 |
9 |
| The Trustees of the University of Pennsylvania | 4406 |
9 |
| Repligen Corporation | 293 |
9 |
| The Johns Hopkins University | 5798 |
8 |
| GE Healthcare BioProcess R&D AB | 42 |
8 |
| Abvacc, Inc. | 13 |
8 |
| Bristol-myers Squibb Company | 4821 |
7 |
| Other owners | 498 |